These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 9152770)

  • 1. Heterogeneity of myocardial fluoro-18 2-deoxyglucose uptake in patients with apical hypertrophic cardiomyopathy.
    Shiba N; Kagaya Y; Ishide N; Otani H; Takeyama D; Yamane Y; Chida M; Ikeda J; Ido T; Shirato K
    Jpn Circ J; 1997 Mar; 61(3):223-30. PubMed ID: 9152770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in myocardial fluoro-18 2-deoxyglucose uptake in young versus older patients with hypertrophic cardiomyopathy.
    Kagaya Y; Ishide N; Takeyama D; Kanno Y; Yamane Y; Shirato K; Maruyama Y; Itoh M; Ido T; Matsuzawa T
    Am J Cardiol; 1992 Jan; 69(3):242-6. PubMed ID: 1731466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myocardial glucose metabolism is different between hypertrophic cardiomyopathy and hypertensive heart disease associated with asymmetrical septal hypertrophy.
    Shiba N; Kagaya Y; Ishide N; Takeyama D; Yamane Y; Chida M; Otani H; Ido T; Shirato K
    Tohoku J Exp Med; 1997 Jun; 182(2):125-38. PubMed ID: 9261931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myocardial blood flow and metabolism in patients with hypertrophic cardiomyopathy--a study with carbon-11 acetate and positron emission tomography.
    Ishiwata S; Maruno H; Senda M; Toyama H; Nishiyama S; Seki A
    Jpn Circ J; 1997 Mar; 61(3):201-10. PubMed ID: 9152767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myocardial glucose metabolism in patients with hypertrophic cardiomyopathy: assessment by F-18-FDG PET study.
    Uehara T; Ishida Y; Hayashida K; Shimonagata T; Miyake Y; Sago M; Oka H; Nagata S; Miyatake K; Nishimura T
    Ann Nucl Med; 1998 Apr; 12(2):95-103. PubMed ID: 9637280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evaluation of myocardial glucose utilization of hypertrophic and dilated cardiomyopathy using 18F-2-fluoro 2-deoxy-D-glucose and positron emission tomography].
    Ohtake T; Kosaka N; Watanabe T; Momose T; Nishikawa J; Sasaki Y; Iio M; Yokoyama I; Iizuka M; Sugimoto T
    Nihon Rinsho; 1991 Jan; 49(1):143-7. PubMed ID: 2002593
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical analysis of myocardial perfusion and metabolism in patients with hypertrophic cardiomyopathy by single photon emission tomography and positron emission tomography.
    Ishida Y; Nagata S; Uehara T; Yasumura Y; Fukuchi K; Miyatake K
    J Cardiol; 2001; 37 Suppl 1():121-8. PubMed ID: 11433815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myocardial metabolic changes in hypertrophic cardiomyopathy.
    Tadamura E; Tamaki N; Matsumori A; Magata Y; Yonekura Y; Nohara R; Sasayama S; Yoshibayashi M; Kamiya T; Konishi J
    J Nucl Med; 1996 Apr; 37(4):572-7. PubMed ID: 8691242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of myocardial glucose metabolism in hypertrophic cardiomyopathy using 18F-fluorodeoxyglucose positron emission tomography.
    Aoyama R; Takano H; Kobayashi Y; Kitamura M; Asai K; Amano Y; Kumita SI; Shimizu W
    PLoS One; 2017; 12(11):e0188479. PubMed ID: 29176885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regional myocardial blood flow and metabolism at rest in mildly symptomatic patients with hypertrophic cardiomyopathy.
    Grover-McKay M; Schwaiger M; Krivokapich J; Perloff JK; Phelps ME; Schelbert HR
    J Am Coll Cardiol; 1989 Feb; 13(2):317-24. PubMed ID: 2783595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impairment of BMIPP uptake precedes abnormalities in oxygen and glucose metabolism in hypertrophic cardiomyopathy.
    Tadamura E; Kudoh T; Hattori N; Inubushi M; Magata Y; Konishi J; Matsumori A; Nohara R; Sasayama S; Yoshibayashi M; Tamaki N
    J Nucl Med; 1998 Mar; 39(3):390-6. PubMed ID: 9529280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced myocardial 18F-2-fluoro-2-deoxyglucose uptake after orthotopic heart transplantation assessed by positron emission tomography.
    Rechavia E; de Silva R; Kushwaha SS; Rhodes CG; Araujo LI; Jones T; Maseri A; Yacoub MH
    J Am Coll Cardiol; 1997 Aug; 30(2):533-8. PubMed ID: 9247529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simple quantification of regional myocardial uptake of fluorine-18-deoxyglucose in the fasting condition.
    Tamaki N; Yonekura Y; Kawamoto M; Magata Y; Sasayama S; Takahashi N; Nohara R; Kambara H; Kawai C; Konishi J
    J Nucl Med; 1991 Nov; 32(11):2152-7. PubMed ID: 1941154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regional systolic function, myocardial blood flow and glucose uptake at rest in hypertrophic cardiomyopathy.
    Perrone-Filardi P; Bacharach SL; Dilsizian V; Panza JA; Maurea S; Bonow RO
    Am J Cardiol; 1993 Jul; 72(2):199-204. PubMed ID: 8328384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidental spade-shaped FDG uptake in the left ventricular apex suggests apical hypertrophic cardiomyopathy.
    Katagiri M; Nakahara T; Murata M; Ogata Y; Matsusaka Y; Iwabuchi Y; Yamada Y; Fukuda K; Jinzaki M
    Ann Nucl Med; 2017 Jun; 31(5):399-406. PubMed ID: 28364376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myocardial viability: fluorine-18-deoxyglucose positron emission tomography in prediction of wall motion recovery after revascularization.
    Knuuti MJ; Saraste M; Nuutila P; Härkönen R; Wegelius U; Haapanen A; Bergman J; Haaparanta M; Savunen T; Voipio-Pulkki LM
    Am Heart J; 1994 Apr; 127(4 Pt 1):785-96. PubMed ID: 8154416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of low-dose dobutamine-gradient-echo magnetic resonance imaging and positron emission tomography with [18F]fluorodeoxyglucose in patients with chronic coronary artery disease. A functional and morphological approach to the detection of residual myocardial viability.
    Baer FM; Voth E; Schneider CA; Theissen P; Schicha H; Sechtem U
    Circulation; 1995 Feb; 91(4):1006-15. PubMed ID: 7850935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An evaluation of myocardial fatty acid and glucose uptake using PET with [18F]fluoro-6-thia-heptadecanoic acid and [18F]FDG in Patients with Congestive Heart Failure.
    Taylor M; Wallhaus TR; Degrado TR; Russell DC; Stanko P; Nickles RJ; Stone CK
    J Nucl Med; 2001 Jan; 42(1):55-62. PubMed ID: 11197981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regional myocardial perfusion and metabolism assessed by positron emission tomography in children with Kawasaki disease and significance of abnormal Q waves and their disappearance.
    Yoshibayashi M; Tamaki N; Nishioka K; Matsumura M; Ueda T; Temma S; Yonekura Y; Yamashita K; Konishi J; Mikawa H
    Am J Cardiol; 1991 Dec; 68(17):1638-45. PubMed ID: 1746466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regional myocardial blood flow and glucose utilization in symptomatic patients with hypertrophic cardiomyopathy.
    Nienaber CA; Gambhir SS; Mody FV; Ratib O; Huang SC; Phelps ME; Schelbert HR
    Circulation; 1993 May; 87(5):1580-90. PubMed ID: 8491014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.